Ann: FIH Data Confirms Optimal Valve Positioning with ComASUR, page-12

I am interested in this company and think the IP could be worth billions. It irks me how much time and effort the company assigns to promotion and investment (to help the ongoing funding cycle). The data does speak for itself and those who are watching know this. They also know that valuable IP is worth nothing if funding and execution aren't there. I am willing to re-invest into this company once the funding question mark is once and for all removed. From this point there's still huge execution risk and I hope they make better decisions (eg hiring a sales force to sell their tissue products and making next to no progress over many years) on how capital is allocated. For now it makes no sense (to me) to invest now, the risk:reward will get a lot better once the funding question mark is removed. Even if there's a deal inked tomorrow, there will be plenty of time to invest in this stock given how long it takes ASX listed medical and biotech stocks to re-rate (let alone one that has a history like Anteris/Admedus/Allied Health Care)